Rubius Therapeutics, Inc. (RUBY) Social Stream



Rubius Therapeutics, Inc. (RUBY): $0.06

0.00 (2.70%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

Add RUBY to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#153 of 398

in industry

Featured Post From StockTwits About RUBY

$RUBY New SEC Filing: 8-K Earnings - Rubius Therapeutics, Inc. (0001709401) August 09


Item 2.02. Results of Operations and Financial Condition. On August 9, 2021, Rubius Therapeutics, Inc. (the "Company") announced its financial results for the quarter ended June 30, 2021. A copy of the press release issued in connection with the announcement is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing (...)

https://mkn.re/91986
MarketNewswire, published August 9, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!